C Champions Oncology Inc
C
Закрыт
СекторЗдравоохранение
6.47 4.86
Обзор
Изменение цены акций
24 ч
Мин.
6.39
Макс.
6.47
Доход | -514K -278K |
|---|---|
Продажи | 1.5M 17M |
P/E Средняя по отрасли | 35.118 49.052 |
Прибыль на акцию | -0.02 |
Рентабельность продаж | -1.679 |
Сотрудники | 213 |
EBITDA | -458K 154K |
Следующий отчет о доходах | 22 июл. 2026 г. |
|---|
Рыночная капитализация | -4.6M 78M |
|---|---|
Предыдущая цена открытия | 1.61 |
Предыдущая цена закрытия | 6.47 |
Новостные настроения
By Acuity
100%
0%
330 / 342 Рейтинг в Healthcare
Champions Oncology Inc График
Прошлые результаты не являются надежным индикатором будущих результатов.
О компании Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
